| Zhang, Yue |
| Active, not recruiting | 4 | 800 | RoW | Sodium Oligomannate Capsules (GV-971) | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | Alzheimer Disease | 01/25 | 06/25 | | |
SPH3127-301, NCT05359068: Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension |
|
|
| Completed | 3 | 957 | RoW | SPH3127 tablet, Valsartan | Shanghai Pharmaceuticals Holding Co., Ltd | Essential Hypertension | 12/23 | 12/23 | | |
NCT04919642: Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma |
|
|
| Completed | 2 | 55 | US | TT-00420 | TransThera Sciences (Nanjing), Inc. | Cholangiocarcinoma, FGFR2 Fusion, FGFR2 Gene Mutation, FGFR1 Alteration, FGFR3 Alteration | 02/24 | 02/24 | | |
NCT05630183: A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer |
|
|
| Recruiting | 2 | 78 | US | Botensilimab, AGEN1181, Gemcitabine, Nab-paclitaxel | Agenus Inc. | Metastatic Pancreatic Ductal Adenocarcinoma | 12/24 | 12/24 | | |
|
NCT03450603: Predicting Risk Factors for Exacerbation of Chronic Obstructive Pulmonary Disease |
|
|
| Recruiting | N/A | 200 | RoW | | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Chronic Obstructive Pulmonary Disease | 12/24 | 12/24 | | |
NCT05948046: The Health-Related Quality of Life of the Patients With Symptomatic Convergence Insufficiency |
|
|
| Recruiting | N/A | 300 | RoW | Visual training in hospital | Tianjin Eye Hospital | Myopia, Convergence Insufficiency | 04/24 | 06/24 | | |
| Houck, William |
| Completed | 3 | 287 | US, RoW | Crofelemer 125 MG [Mytesi], Placebo | Napo Pharmaceuticals, Inc. | Cancer Therapy-Related Diarrhea, Chemotherapy-related Diarrhea, Adult Solid Tumor, Prophylaxis of Diarrhea, Symptomatic Relief of Diarrhea, Targeted Therapy-related Diarrhea | 08/23 | 10/23 | | |
| Active, not recruiting | 3 | 368 | Europe, US, RoW | Abemaciclib, Fulvestrant, Placebo | Eli Lilly and Company, Eli Lilly and Company | Breast Neoplasm, Neoplasm Metastasis | 02/24 | 02/26 | | |
NCT05630183: A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer |
|
|
| Recruiting | 2 | 78 | US | Botensilimab, AGEN1181, Gemcitabine, Nab-paclitaxel | Agenus Inc. | Metastatic Pancreatic Ductal Adenocarcinoma | 12/24 | 12/24 | | |
|
